TC | 
Stat | 
Stk | 
Ins | 
Fil | 
+d | 
+w | 
+m | 
+q | 
+h | 
+y | 
avg | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | -3 | -1 | 17 | 31 | -90 | -98 | -24 | 
| S | %wins | 67 | 67 | 33 | 0 | 100 | 100 | 61 | 
Filing Date | 
					T Date | 
					Ticker | 
					Issuer | Inc | 					Sector | 
					Ind | Industry |  
						Owner | 
						oSt | 
						Rel | 
						Title | 
					 
					T | 
					TVal | 
					Price | 
					L | 
					Qty | 
					oc | 
					Own | 
					H | 
					r2y | 
					r1y | 
					r6m | 
					r3m | 
					r6w | 
					r3w | 
					r7d | 
					r3d | 
					f1d | 
					f1w | 
					f1m | 
					f3m | 
					f6m | 
					f1y | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/12/15 18:28  | 1/9/15  | CLDN | Celladon Corp | DE | Health | BioPrd | Biological Products, (No Diag | Rudy Jeffrey J | CA | O | VP,Clini | S.d | -185 | 18.51 | 6 | -10 | -91 | 1 | D | 46 | 95 | 49 | 0 | -5 | 10 | -2 | -2 | -14 | 3 | -92 | |||
12/10/14 18:43  | 12/9/14  | CLDN | Celladon Corp | DE | Health | BioPrd | Biological Products, (No Diag | Rudy Jeffrey J | CA | O | VP,Clini | S.d | -150 | 15.00 | 2 | -10 | -96 | 0 | D | 49 | 48 | 52 | 37 | 29 | 27 | -9 | -2 | 3 | 48 | -100 | -106 | ||
11/18/14 16:05  | 11/14/14  | CLDN | Celladon Corp | DE | Health | BioPrd | Biological Products, (No Diag | Rudy Jeffrey J | CA | O | VP,Clini | S.d | -210 | 11.67 | 1 | -18 | -100 | 0 | D | 22 | 0 | 22 | 12 | 0 | -4 | 2 | 2 | 62 | 41 | -79 | -90 | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |